Detalles de la búsqueda
1.
Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective.
Regul Toxicol Pharmacol
; 117: 104746, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32911461
2.
Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial.
Lipids Health Dis
; 4: 30, 2005 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16329761
3.
A non-human primate model for investigating drug-induced risk of orthostatic hypotension and sympathetic dysfunction: Preclinical correlate to a clinical test.
J Pharmacol Toxicol Methods
; 73: 49-55, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25837852
4.
Comment on: Parkinson's Disease, Religion, and Spirituality.
Mov Disord Clin Pract
; 3(5): 518, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-30363544
5.
Side of onset in Parkinson's disease and alterations in religiosity: novel behavioral phenotypes.
Behav Neurol
; 24(2): 133-41, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21606574
6.
Disease-associated differences in religious cognition in patients with Parkinson's disease.
J Clin Exp Neuropsychol
; 33(8): 917-28, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21656414
7.
Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
J Pharmacol Toxicol Methods
; 58(1): 59-68, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18585469
Resultados
1 -
7
de 7
1
Próxima >
>>